La maladie de Parkinson au Canada (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Dopamine D2 Receptor Antagonists »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dopamine Antagonists (toxicity) < Dopamine D2 Receptor Antagonists < Dopamine Plasma Membrane Transport Proteins  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000633 (2006) Kaveh M. Koochesfahani [Canada] ; Raúl De La Fuente-Fernández ; Vesna Sossi ; Michael Schulzer ; Lakshmi N. Yatham ; Thomas J. Ruth ; Stephan Blinder ; A Jon StoesslOral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: positron emission tomographic studies.
001353 (2013) James B. Koprich [Canada] ; Philippe Huot ; Susan H. Fox ; Keith Jarvie ; Anthony E. Lang ; Philip Seeman ; Jonathan M. BrotchieThe effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques.
001643 (2013) Leigh Christopher [Canada] ; Connie Marras [Canada] ; Sarah Duff-Canning [Canada] ; Yuko Koshimori [Canada] ; Robert Chen [Canada] ; Isabelle Boileau [Canada] ; Barbara Segura [Canada, Espagne] ; Oury Monchi [Canada] ; Anthony E. Lang [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Antonio P. Strafella [Canada]Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson’s disease with mild cognitive impairment
002426 (1993) C. Gagnon [Canada] ; B. Gomez-Mancilla ; P J Bédard ; T. Di PaoloChronic CY 208-243 treatment of MPTP-monkeys causes regional changes of dopamine and GABAA receptors.
002471 (1993) P. Seeman [Canada] ; H C Guan ; H H Van Tol ; H B NiznikLow density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata.
002533 (1996) J P Doucet [Canada] ; Y. Nakabeppu ; P J Bedard ; B T Hope ; E J Nestler ; B J Jasmin ; J S Chen ; M J Iadarola ; M. St-Jean ; N. Wigle ; P. Blanchet ; R. Grondin ; G S RobertsonChronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.
002603 (1998) P. Seeman [Canada] ; R. Corbett ; H H Van TolDopamine D4 receptors may alleviate antipsychotic-induced parkinsonism.
002640 (1998) P. Seeman [Canada] ; T. TallericoAntipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Dopamine D2 Receptor Antagonists" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Dopamine D2 Receptor Antagonists" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dopamine D2 Receptor Antagonists
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022